CuraTeQ Bio Completes Ph 3 Study for Denosumab Biosimilar
19 Sep 2025 //
INDPHARMAPOST
Aurobindo Pharma Nears $5.5b Zentiva Acquisition
20 Aug 2025 //
ECONOMICTIMES
Aurobindo to Produce, Supply Long Acting HIV Treatment Drug
15 Jul 2025 //
ECONOMICTIMES
Aurobindo arm gets USFDA nod for generic blood cancer drug
24 Apr 2025 //
ECONOMICTIMES
Aurobindo gets final approval for Rivaroxaban Tablets
15 Apr 2025 //
INDPHARMAPOST
Eugia Pharma receives FDA approval for Pazopanib Tablets, 200 mg
09 Dec 2024 //
INDPHARMAPOST
An Indian industrialist wants to buy Biogaran, the French number one in generics
18 Apr 2024 //
20MINUTES
Aurobindo Pharma gets USFDA nod for generic antifungal injection
27 Dec 2023 //
ECONOMIC TIMES
Aurobindo Pharma gets U.S. FDA nod for generic Icatibant injection
16 Aug 2023 //
THE HINDU
Eugia signs voluntary license with Medicines Patent Pool to develop Nilotinib
23 Jun 2023 //
INDIANPHARMAPOST
GSK licenses companies to make cheap copies of HIV prevention drug
30 Mar 2023 //
REUTERS
Aurobindo Pharma’s US branch issues a recall of a generic medicine
26 Oct 2022 //
ENDPTS
Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
27 Aug 2021 //
ECONOMICTIMES
Aurobindo Pharma receives US FDA approval for generic Precedex
08 Dec 2020 //
PHARMABIZ
Aurobindo is finding it difficult to satisfy the FDA, or the FTC
07 Nov 2019 //
FIERCE PHARMA
Where is that Sandoz U.S. generics deal with Aurobindo?
24 Oct 2019 //
FIERCE PHARMA
Old guard` generics players yield U.S. scripts lead
18 Apr 2019 //
FIERCE PHARMA
Manufacturing cuts likely in remake of Sandoz
02 Feb 2019 //
FIERCE PHARMA
‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts
01 Feb 2019 //
FIERCE PHARMA
Novartis plans more ‘autonomy’ for Sandoz. But NO spinoff
15 Nov 2018 //
FIERCE PHARMA
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Aurobindo Pharma
15 Sep 2018 //
PATENT LITIGATION
Who’s losing on Aurobindo-Novartis generics deal? Teva and Mylan- analyst
08 Sep 2018 //
FIERCE PHARMA
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
OTEZLA® (apremilast): Celgene Corporation v. Aurobindo Pharma Limited
11 Jul 2018 //
PATENT LITIGATION
OTEZLA® (apremilast): Celgene Corporation v. Aurobindo Pharma Limited, et al.
09 Jul 2018 //
PATENT LITIGATION
Vesicare® (Solifenacin Succinate) : Astellas Pharma Inc. v. Aurobindo Pharma
25 Jun 2018 //
PATENT LITIGATION
Aurobindo launches $1.6 billion bid to buy Novartis generics unit
08 May 2018 //
LIVEMINT
Bystolic® (Nebivolol Hydrochloride): Allergan Sales V. Aurobindo Pharma Usa
19 Jan 2018 //
PATENT LITIGATION
Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injection
27 Dec 2017 //
ECONOMIC TIMES
Prezista® (Darunavir): Janssen Sciences Ireland Uc, V. Aurobindo Pharma
07 Sep 2017 //
PATENT LITIGATION
Aurobindo to widen US portfolio, enter new markets in Europe
21 Aug 2017 //
ECONOMIC TIMES
Aurobindo Pharma, Intas in race to buy Mallinckrodt`s US generic business
09 Aug 2017 //
MONEYCONTROL
Aurobindo Pharma looks to push deeper into EU, US over next 3-4 years
03 Jul 2017 //
ECONOMIC TIMES
The top 15 generic drugmakers by 2016 revenue
16 May 2017 //
FIERCE PHARMA
Sun Pharma, Torrent, DRL & Lupin CLSA’s top pharma picks
14 Apr 2017 //
ECONOMIC TIMES
Maryland Lawmakers Pass Generic Drug Price Gouging Bill
10 Apr 2017 //
RAPS
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Aurobindo Pharma
05 Apr 2017 //
PATENT LITIGATION
US court favours Aurobindo in patent case on cough & cold drug
14 Mar 2017 //
BUSINESS-STANDARD
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
Aurobindo Pharma to Buy Portugal`s Generis for 135 Mn Euro
10 Jan 2017 //
ECONOMIC TIMES
The Man The Feds Are Using To First Crack Open Their Big Antitrust Case
15 Dec 2016 //
FORBES
Indian Firms Get Approval For Generics of AstraZeneca’s Crestor
20 Jul 2016 //
BLOOMBERG
Generic Crestor market to become crowded in near future
23 May 2016 //
TWO FOUR INSIGHT
Aurobindo Pharma gets USFDA nod for antibiotic drug
30 Mar 2016 //
ECONOMIC TIMES
How faster USFDA nods will help Indian generic drug makers
31 Aug 2015 //
THE ECONOMIC TIMES
Aurobindo Pharma files ANDA for HIV generic drug
27 May 2015 //
BIOSPECTRUM ASIA
Aurobindo Pharma gets USFDA nod to sell antibiotic oral suspension
14 Apr 2015 //
THE ECONOMIC TIMES
Aurobindo Sells Stake in Australian Arm to Eris Pharma
10 Apr 2015 //
BUSINESS TODAY
Plethico to Pay Aurobindo Pharma $23.3 Million to Settle Dispute
09 Apr 2015 //
THE ECONOMIC TIMES

Market Place
Sourcing Support